Engineers Gate Manager LP

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$204,902

-$53,530 QoQ

Shares Held

98,511

-7.0% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#98

of 209 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $199,313,913 across 163 Biotechnology names. ALLO ranks #128 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$204,902	98,511	-7.0%	Shares	Sole	2026-08-14
2026-03-31	$258,432	105,915	+190.6%	Shares	Sole	2026-05-15
2025-09-30	$45,193	36,446	+12.3%	Shares	Sole	2025-11-14
2025-06-30	$36,685	32,465	-32.0%	Shares	Sole	2025-08-14
2024-09-30	$133,764	47,773	-50.1%	Shares	Sole	2024-11-14
2023-06-30	$475,857	95,746	-5.5%	Shares	Sole	2023-08-14
2023-03-31	$500,743	101,365	-25.0%	Shares	Sole	2023-05-15
2022-12-31	$849,646	135,079	+180.6%	Shares	Sole	2023-02-14
2022-09-30	$519,955	48,144	+139.5%	Shares	Sole	2022-11-14
2021-12-31	$299,966	20,105	-8.5%	Shares	Sole	2022-02-14
2021-06-30	$573,238	21,980	+123.6%	Shares	Sole	2021-08-16
2021-03-31	$346,999	9,830	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.